宫外壮症的临床和生化谱系
Patricia Fainstein-Day1, Tamara Estefanía Ullmann2, Mercedes Corina Liliana Dalurzo3
1Endocrinology, Metabolism and Nuclear Medicine Department, Hospital Italiano de Buenos Aires (HIBA), Instituto de Medicina Traslacional e Ingeniería Biomédica (IMTIB), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Instituto Universitario del Hospital Italiano de Buenos Aires, Tte. Gral. Juan Domingo Perón 4190, Buenos Aires, CP C1199ABB, Argentina.
宫外巨,由罕见的神经内分泌瘤 (NETs) 产生的生长激素释放激素 (GHRH),可以被误诊. 通过血清GHRH测量和手术切除GHRH分泌NET的早期诊断提供了治疗方法.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
- 神经外科 神经外科
背景情况:
- 异位性缩瘤是一种罕见的内分泌疾病 (<1%的缩瘤病例),起源于外垂体神经内分泌瘤 (NETs).
- 这些瘤高分泌生长激素 (GH) 或更常见的是GH释放激素 (GHRH),导致误诊和不适当的垂体手术.
- 存在四种亚型:中央/外围GH分泌和中央/外围GH分泌,其中外围GH分泌是最常见的.
研究的目的:
- 为了区分子宫外巨与经典的垂体腺瘤.
- 突出诊断挑战和确定激素过分分泌的来源的重要性.
- 强调外科手术治疗疗效的有效性.
主要方法:
- 对描述的宫外巨病例的审查.
- 讨论诊断成像技术 (截面成像,MRI) 和它们的局限性.
- 强调测量血清GHRH水平作为一种特定的诊断工具.
主要成果:
- 通过NETs (肺,胰腺) 产生的外周GHRH分泌是外宫缩病的最常见原因.
- 由于慢性GHGH刺激而导致的垂体增生症可以在MRI上模仿垂体腺瘤.
- 血清GHRH测量是一种关键的诊断辅助.
结论:
- 准确诊断宫外缩症需要排除宫外垂体腺瘤,并确定激素过分分泌的来源.
- 迅速切除GHGH分泌NET的手术往往可以治愈.
- 意识到子宫外壮症至关重要,以防止误诊和不有效的治疗.
相关概念视频
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Hypoglycemia and Glucagon
Acute Pancreatitis II: Clinical Manifestations and Management
Major Hormones and Their Functions
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and...
Smooth Endoplasmic Reticulum
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
Chronic Pancreatitis II: Collaborative Care
Assessment:


